Internal Medicine · High Point, NC
NPI
1730193665
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3604 Peters Ct
High Point, NC, 27265
Phone (336) 883-0029
Groups this clinician bills Medicare through
Medicare paid, 2024
$148K
4,967 services
Medicare patients, 2024
133
Average age 72
Drug cost, 2024
$2.3M
18,547 prescriptions
Company payments, 2025
$1,908
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Moogali M Arvind was code 99214 (office e&m - established), 554 times for 120 patients. In total Moogali M Arvind billed 4,967 services in 106 codes, and Medicare paid $148K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-07-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 554 | 120 | $78.88 | $44K |
| 36415 Venipuncture Blood Collection | Office | 284 | 98 | $8.62 | $2,448 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 279 | 90 | $11.25 | $3,140 |
| 85025 Blood Count | Office | 275 | 99 | $7.50 | $2,062 |
| 80053 Clinical Chemistry | Office | 264 | 97 | $10.28 | $2,714 |
| 83970 Clinical Chemistry | Office | 257 | 99 | $39.82 | $10K |
| 80061 Clinical Chemistry | Office | 254 | 97 | $13.07 | $3,319 |
| 82306 Clinical Chemistry | Office | 202 | 99 | $28.45 | $5,747 |
| 80307 Drug Tests | Office | 177 | 40 | $60.52 | $11K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 173 | 18 | $0.09 | $14.76 |
| 81002 Clinical Chemistry | Office | 165 | 66 | $3.33 | $549 |
| 99213 Office E&M - Established | Office | 140 | 69 | $54.16 | $7,583 |
| 83036 Blood Count | Office | 120 | 57 | $9.36 | $1,123 |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 112 | 32 | $112.14 | $13K |
| 82044 Clinical Chemistry | Office | 109 | 54 | $5.89 | $642 |
By year: 2022 $327K for 11,610 services; 2023 $235K for 8,222 services; 2024 $148K for 4,967 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 284 | 98 | $8.62 | $2,448 |
| 85025 Blood Count | 275 | 99 | $7.50 | $2,062 |
| 80053 Clinical Chemistry | 264 | 97 | $10.28 | $2,714 |
| 83970 Clinical Chemistry | 257 | 99 | $39.82 | $10K |
| 80061 Clinical Chemistry | 254 | 97 | $13.07 | $3,319 |
| 82306 Clinical Chemistry | 202 | 99 | $28.45 | $5,747 |
| 80307 Drug Tests | 177 | 40 | $60.52 | $11K |
| 81002 Clinical Chemistry | 165 | 66 | $3.33 | $549 |
| 83036 Blood Count | 120 | 57 | $9.36 | $1,123 |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 112 | 32 | $112.14 | $13K |
Medicare prescription drug claims, 2024
In 2024, the drug Moogali M Arvind prescribed most often to Medicare patients was Oxycodone Hcl, with 690 prescriptions and refills. In total Moogali M Arvind wrote 18,547 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 690 | 690 | 92 | $11K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 625 | 625 | 83 | $63K |
| Gabapentin Generic | 588 | 896 | 126 | $11K |
| Atorvastatin Calcium Generic | 584 | 1,349 | 150 | $4,430 |
| Farxiga Dapagliflozin Propanediol | 462 | 693 | 89 | $386K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 426 | 434 | 63 | $13K |
| Celecoxib Generic | 420 | 597 | 101 | $7,540 |
| Levothyroxine Sodium Generic | 416 | 1,035 | 103 | $3,004 |
| Rosuvastatin Calcium Generic | 397 | 870 | 96 | $2,722 |
| Omeprazole Generic | 366 | 832 | 95 | $5,795 |
| Losartan Potassium Generic | 356 | 904 | 93 | $2,770 |
| Furosemide Generic | 352 | 656 | 86 | $1,219 |
| Tizanidine Hcl Generic | 341 | 417 | 65 | $2,564 |
| Jardiance Empagliflozin | 297 | 396 | 50 | $236K |
| Allopurinol Generic | 270 | 606 | 64 | $2,030 |
Brand drugs: 2,954 claims; generic drugs: 15,469 claims; opioid claims: 2,280.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Moogali M Arvind $1,908 ($1,908 in general payments such as food, travel and fees) from 23 companies. The largest payer was Novo Nordisk Inc with $381.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 16 | $381 |
| Lilly USA, LLC LLY | 12 | $293 |
| Abbvie Inc. ABBV | 16 | $195 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $163 |
| Pfizer Inc. PFE | 19 | $160 |
| Collegium Pharmaceutical, Inc. COLL | 7 | $136 |
| Harmony Biosciences LLC HRMY | 4 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $75.62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $70.12 |
| Lundbeck LLC | 3 | $64.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.